ArticleFrontiers in oncology2021

HOXA5 Is Recognized as a Prognostic-Related Biomarker and Promotes Glioma Progression Through Affecting Cell Cycle.

Fengqin Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.